Overexpression of MCM6 may predict the unfavorable survival outcomes of patients with glioma [134], hepatocellular carcinoma (HCC) [135] and endometrioid endometrial adenocarcinoma [136]. The gene discussed is MCM6; the disease is endometrial endometrioid adenocarcinoma.